Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.98)
# 487
Out of 4,843 analysts
38
Total ratings
52.63%
Success rate
12.09%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FENC Fennec Pharmaceuticals | Maintains: Buy | $12 → $13 | $8.15 | +59.61% | 5 | May 14, 2025 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $28 | $18.92 | +47.99% | 6 | May 14, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $5.04 | +28.97% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $21.25 | +83.53% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $0.63 | +1,166.83% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $17.06 | +23.09% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $2.86 | +109.79% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $3.55 | +238.03% | 2 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $2.79 | +258.42% | 1 | Nov 4, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $12.41 | +28.93% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $65 | $27.20 | +138.97% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $6.55 | +83.21% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.07 | +41.44% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $9.22 | +149.59% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.70 | +71.67% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $4.31 | +387.24% | 1 | Mar 13, 2023 |
Fennec Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $12 → $13
Current: $8.15
Upside: +59.61%
Eton Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $26 → $28
Current: $18.92
Upside: +47.99%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $5.04
Upside: +28.97%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $21.25
Upside: +83.53%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.63
Upside: +1,166.83%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $17.06
Upside: +23.09%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $2.86
Upside: +109.79%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $3.55
Upside: +238.03%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $2.79
Upside: +258.42%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $12.41
Upside: +28.93%
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $27.20
Upside: +138.97%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $6.55
Upside: +83.21%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $7.07
Upside: +41.44%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $9.22
Upside: +149.59%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.70
Upside: +71.67%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $4.31
Upside: +387.24%